Vasalgel highlighted in NYT debate
What better way to start the New Year than informing the public about the importance of male contraception? Elaine Lissner, Director of Parsemus Foundation and
What better way to start the New Year than informing the public about the importance of male contraception? Elaine Lissner, Director of Parsemus Foundation and
It’s happening! After months of planning and fundraising, we’ve decided to take the plunge: the last animal study of Vasalgel before human trials. Thanks to
Where was calcium chloride? New York Times journalist Douglas Quenqua focused the article on Zeuterin, a product likely to come out in the US shortly,
Why don’t we have a male birth control pill? What is the status of RISUG? Why is Vasalgel being promoted by a nonprofit instead of
Read this before you or a loved one considers having a stent implanted! Doctors continue to overuse stents to treat stable coronary artery diseases despite
Did you know that of the 700 million dogs in the world, over 75% of them are free roaming? This creates unchecked reproduction and is
Thanks to everyone who has donated to help get Vasalgel™ male contraceptive to market! Since our progress announcement last week, supporters have chipped in 1/4
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: